ities fraud class action that claims the investment bank made misleading statements that caused the stock price of a shuttered fintech corporation, Longfin, to skyrocket in late 2017. Order attached I Read full article » Cancer Biotech Oasmia Hid Deals From Investors, Suit Says Investors for Swedish c